For those not taking GLP-1 medications, these eating habits can naturally support better appetite regulation since GLP-1 slows digestion, allowing us to feel full for longer
The importance of DNL in NAFLD is further supported by studies, showing that in obese patients with NAFLD, approximately 26% of hepatic triglycerides were derived from DNL and that these patients were unable to regulate DNL when transitioning from fasting to fed state [40]
Wearables and biosensors provide a constant flow of health data, allowing physicians to adjust treatment regimens as their patients age
Cost transparency removes a major barrier: PlexusDx publishes all pricing upfront, so you know exactly what you'll pay each month before your first injection or tablet arrives
Without strong human studies on the exact product, it is difficult to know whether the patch meaningfully changes appetite, weight, or glucose control
GLP-1 receptor agonists are medicines that act like GLP-1